Human Endocrine Gland Vascular Endothelial Growth Factor Recombinant
$70.00 – $2,700.00
| accession | P58294 |
| Source | Optimized DNA sequence encoding Human EG-VEGF mature chain was expressed in Escherichia Coli. |
| Molecular weight | Native human EG-VEGF is generated by the proteolytic removal of the signal peptide, This molecule has a calculated molecular mass of approximately 10 kDa. Recombinant EG-VEGF is a monomer protein consisting of 86 amino acid residue subunits,and migrates as an approximately 10 kDa protein under reducing conditions in SDS-PAGE. |
| Purity | >98%, as determined by SDS-PAGE and HPLC |
| Protein Sequence | MRGATRVSIM LLLVTVSDCA VITGACERDV QCGAGTCCAI SLWLRGLRMC TPLGREGEEC HPGSHKVPFF RKRKHHTCPC LPNLLCSRFP DGRYRCSMDL KNINF |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg(1EU/µg). |
| Presentation | Recombinant EG-VEGFwas lyophilized from a.2 μm filtered PBS solution. |
| Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than.1 mg/mL. This solution can then be diluted into other buffers. |
| Storage | The lyophilized protein is stable for at least years from date of receipt at -20° C. Upon reconstitution, this cytokine can be stored in working aliquots at° -° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
| Usage | This cytokine product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
| Biological Process | Angiogenesis |
| Molecular function | Growth-factor |
| Molecular function | Mitogen |
Methods
Expression of PROK1 and PROKR1 mRNA in human uteroplacental tissues at term.
|